PharmaTher Holdings to resubmit information on ketamine NDA to US FDA by end of February 2025: Toronto Saturday, February 15, 2025, 18:00 Hrs [IST] PharmaTher Holdings Ltd, a spec ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback